We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abbott Wins Injunction to Block Generic Biaxin XL
Abbott Wins Injunction to Block Generic Biaxin XL
November 15, 2005
In what one analyst called a “significant negative” for beleaguered Andrx, a federal court has granted Abbott Laboratories a preliminary injunction against Andrx and Ranbaxy Laboratories marketing their versions of Biaxin XL.